Browse Our Resources

Learn How is Redefining the Ideal Patient


Real World Insights

Using Predictive Intelligence to Uncover the Rare Disease Patient Journey

In this podcast interview, Dan Fisher, managing director and practice lead for, explains the use of artificial...

2023 Survey: Automation Is Ubiquitous for Orphan and Specialty Drug Commercialization

87% of Biopharma Respondents Use AI/ML for Post-Market Activities, But Key Missed Opportunities Remain

NEW YORK — As... In the Orphanet Journal of Rare Diseases: Understanding Healthcare Resource Utilization for US X‑linked Myotubular Myopathy (XLMTM) Patients using Real World Data

By: Dan Fisher, Principal,

X‑linked myotubular myopathy (XLMTM) is a rare, life-threatening congenital...

How Real World Data Revealed the Need for Broad HCP Education of Frontotemporal Dementia

By: Dan Fisher, Principal,

The Challenge  

Frontotemporal dementia (FTD) is the most common form of dementia...

Accelerating Trial Recruitment by Identifying HCPs with a Diverse and Addressable Patient Population

By: Nitin Choudhary, EVP & GM,

Reach diverse, trial eligible patients through the physicians they trust using... Uncovers 47% of New Patients for AVEO Oncology’s FOTIVDA®

By: Nitin Choudhary, EVP & GM,


For rare and specialty oncology, low incidence rates complicate...

More posts




Download Our Case Studies and Publications